161 related articles for article (PubMed ID: 35116329)
1. Down-regulation of PSMD4 can attenuate autophagy, enhance the accumulation of intracellular ROS, and increase the sensitivity of epithelial ovarian cancer to carboplatin by inhibiting the NF-κB pathway.
Li Y; Zhou Q; Shen J; Zhu L
Transl Cancer Res; 2021 Nov; 10(11):4756-4772. PubMed ID: 35116329
[TBL] [Abstract][Full Text] [Related]
2. LHPP promotes the intracellular reactive oxygen species accumulation and sensitivity of gastric cancer to cisplatin via JNK and p38 MAPK pathways.
Gao K; Yin N; Shen Z; Li Q; Chen P; Yang K
Histol Histopathol; 2023 Sep; 38(9):1055-1068. PubMed ID: 36546683
[TBL] [Abstract][Full Text] [Related]
3. Galectin-3 regulates metastatic capabilities and chemotherapy sensitivity in epithelial ovarian carcinoma via NF-κB pathway.
Lu H; Liu Y; Wang D; Wang L; Zhou H; Xu G; Xie L; Wu M; Lin Z; Yu Y; Li G
Tumour Biol; 2016 Aug; 37(8):11469-77. PubMed ID: 27012551
[TBL] [Abstract][Full Text] [Related]
4. Blockade of nuclear factor-κB (NF-κB) pathway inhibits growth and induces apoptosis in chemoresistant ovarian carcinoma cells.
Momeny M; Yousefi H; Eyvani H; Moghaddaskho F; Salehi A; Esmaeili F; Alishahi Z; Barghi F; Vaezijoze S; Shamsaiegahkani S; Zarrinrad G; Sankanian G; Sabourinejad Z; Hamzehlou S; Bashash D; Aboutorabi ES; Ghaffari P; Dehpour AR; Tavangar SM; Tavakkoly-Bazzaz J; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
Int J Biochem Cell Biol; 2018 Jun; 99():1-9. PubMed ID: 29567488
[TBL] [Abstract][Full Text] [Related]
5. Exploration of the sequential gene changes in epithelial ovarian cancer induced by carboplatin via microarray analysis.
Wei S; Liu J; Shi Y; Zhang X; Yang Y; Song Q
Mol Med Rep; 2017 Sep; 16(3):3155-3160. PubMed ID: 28713952
[TBL] [Abstract][Full Text] [Related]
6. FSTL1 increases cisplatin sensitivity in epithelial ovarian cancer cells by inhibition of NF-κB pathway.
Liu YK; Jia YJ; Liu SH; Ma J
Cancer Chemother Pharmacol; 2021 Mar; 87(3):405-414. PubMed ID: 33392640
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatics analysis and verification of molecular targets in ovarian cancer stem-like cells.
Behera A; Ashraf R; Srivastava AK; Kumar S
Heliyon; 2020 Sep; 6(9):e04820. PubMed ID: 32984578
[TBL] [Abstract][Full Text] [Related]
8. RUNX3 contributes to carboplatin resistance in epithelial ovarian cancer cells.
Barghout SH; Zepeda N; Vincent K; Azad AK; Xu Z; Yang C; Steed H; Postovit LM; Fu Y
Gynecol Oncol; 2015 Sep; 138(3):647-55. PubMed ID: 26186909
[TBL] [Abstract][Full Text] [Related]
9. The biphasic role of NF-kappaB in progression and chemoresistance of ovarian cancer.
Yang G; Xiao X; Rosen DG; Cheng X; Wu X; Chang B; Liu G; Xue F; Mercado-Uribe I; Chiao P; Du X; Liu J
Clin Cancer Res; 2011 Apr; 17(8):2181-94. PubMed ID: 21339307
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiles and pathway enrichment analysis to identification of differentially expressed gene and signaling pathways in epithelial ovarian cancer based on high-throughput RNA-seq data.
Siavoshi A; Taghizadeh M; Dookhe E; Piran M
Genomics; 2022 Jan; 114(1):161-170. PubMed ID: 34839022
[TBL] [Abstract][Full Text] [Related]
11. KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells.
Kim KH; Xie Y; Tytler EM; Woessner R; Mor G; Alvero AB
J Transl Med; 2009 Jul; 7():63. PubMed ID: 19619321
[TBL] [Abstract][Full Text] [Related]
12. Abnormal spindle-like microcephaly-associated protein promotes proliferation by regulating cell cycle in epithelial ovarian cancer.
Wu Y; You Y; Chen L; Liu Y; Liu Y; Lou W; Fu F
Gland Surg; 2022 Apr; 11(4):687-701. PubMed ID: 35531115
[TBL] [Abstract][Full Text] [Related]
13. NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells.
Kim KH; Park SH; Do KH; Kim J; Choi KU; Moon Y
Oncotarget; 2016 Nov; 7(44):72148-72166. PubMed ID: 27708225
[TBL] [Abstract][Full Text] [Related]
14. Morusin induces paraptosis-like cell death through mitochondrial calcium overload and dysfunction in epithelial ovarian cancer.
Xue J; Li R; Zhao X; Ma C; Lv X; Liu L; Liu P
Chem Biol Interact; 2018 Mar; 283():59-74. PubMed ID: 29421517
[TBL] [Abstract][Full Text] [Related]
15. Data Mining of Differentially Expressed Genes in Ovarian Epithelial Carcinoma: Implications in Precise Medicine.
Zhao J; Gao H; He Y
Curr Top Med Chem; 2021 Oct; 21(14):1285-1300. PubMed ID: 34238161
[TBL] [Abstract][Full Text] [Related]
16. Differential activation of NF-κB signaling is associated with platinum and taxane resistance in MyD88 deficient epithelial ovarian cancer cells.
Gaikwad SM; Thakur B; Sakpal A; Singh RK; Ray P
Int J Biochem Cell Biol; 2015 Apr; 61():90-102. PubMed ID: 25681684
[TBL] [Abstract][Full Text] [Related]
17. Physcion-8-O-β-d-glucoside interferes with the nuclear factor-κB pathway and downregulates P-glycoprotein expression to reduce paclitaxel resistance in ovarian cancer cells.
Li X; He Y; Wei L; Zhang J; Li X; Cui W; Zhang S
J Pharm Pharmacol; 2021 Mar; 73(4):545-552. PubMed ID: 33793827
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppression through constitutively activated NF-κB signalling in human ovarian cancer and its reversal by an NF-κB inhibitor.
Nishio H; Yaguchi T; Sugiyama J; Sumimoto H; Umezawa K; Iwata T; Susumu N; Fujii T; Kawamura N; Kobayashi A; Park J; Aoki D; Kawakami Y
Br J Cancer; 2014 Jun; 110(12):2965-74. PubMed ID: 24867687
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of RIF1 Enhances Sensitivity to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer (EOC) by Regulating Nucleotide Excision Repair (NER) Pathway.
Liu YB; Mei Y; Tian ZW; Long J; Luo CH; Zhou HH
Cell Physiol Biochem; 2018; 46(5):1971-1984. PubMed ID: 29719287
[TBL] [Abstract][Full Text] [Related]
20. Galectin-1 promotes tumor progression via NF-κB signaling pathway in epithelial ovarian cancer.
Chen L; Yao Y; Sun L; Tang J
J Cancer; 2017; 8(18):3733-3741. PubMed ID: 29151961
[No Abstract] [Full Text] [Related]
[Next] [New Search]
